A phase II study of intrapleural immuno-chemotherapy, pleurectomy/decortication, radiotherapy, systemic chemotherapy and long-term sub-cutaneous IL-2 in stage II-III malignant pleural mesothelioma.
暂无分享,去创建一个
A. Chella | G. Fontanini | A. Mussi | M. Ambrogi | M. Lucchi | F. Melfi | P. Dini | Leonardo Fino